Brett P. Monia, Chief Executive Officer of IONIS PHARMACEUTICALS INC (IONS), sold 117,604 shares of the company's stock on March 11, 2026. The transactions occurred at an average price of $75.26 per share, resulting in a total value of approximately $8.85 million.
This sale follows several other insider transactions at IONIS PHARMACEUTICALS INC. Earlier this week, Monia himself divested shares totaling over $2.5 million across multiple trades on March 10th. Other executives, including Kyle Jenne and Patrick R. O'Neil, also reported selling significant portions of their holdings on March 10th and March 9th, respectively.
Insider sales can be influenced by a variety of personal financial decisions, such as portfolio diversification, tax planning, or adhering to pre-established trading plans. These actions do not necessarily indicate a diminished outlook on the company's future prospects.